Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanco Hefting

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Lancet. Psychiatry|April 10, 2025
Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active referenceCaroline Ward, Milica Pejović Milovančević, Eva Kohegyi, et al.
Journal of Alzheimer'S Disease : JAD|November 13, 2024
Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trialSaloni Behl, Mary Slomkowski, Dalei Chen, et al.
JAMA Neurology|November 6, 2023
Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical TrialDaniel Lee, Mary Slomkowski, Nanco Hefting, et al.
Journal of Affective Disorders|October 21, 2023
Consistency checks to improve measurement with the Young Mania Rating Scale (YMRS)Jonathan Rabinowitz, Robert C Young, Christian Yavorsky, et al.
Journal of Affective Disorders|February 1, 2022
Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D)Jonathan Rabinowitz, Janet B W Williams, Ariana Anderson, et al.
Journal of Affective Disorders|January 13, 2023
Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A)Jonathan Rabinowitz, Janet B W Williams, Nanco Hefting, et al.
CNS Drugs|July 18, 2025
Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension TrialAlpesh Shah, Alvin Estilo, Pamela L Sheridan, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Lancet. Psychiatry|April 10, 2025
Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active referenceCaroline Ward, Milica Pejović Milovančević, Eva Kohegyi, et al.
Journal of Alzheimer'S Disease : JAD|November 13, 2024
Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trialSaloni Behl, Mary Slomkowski, Dalei Chen, et al.
JAMA Neurology|November 6, 2023
Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical TrialDaniel Lee, Mary Slomkowski, Nanco Hefting, et al.
Journal of Affective Disorders|October 21, 2023
Consistency checks to improve measurement with the Young Mania Rating Scale (YMRS)Jonathan Rabinowitz, Robert C Young, Christian Yavorsky, et al.
Journal of Affective Disorders|February 1, 2022
Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D)Jonathan Rabinowitz, Janet B W Williams, Ariana Anderson, et al.
Journal of Affective Disorders|January 13, 2023
Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A)Jonathan Rabinowitz, Janet B W Williams, Nanco Hefting, et al.
CNS Drugs|July 18, 2025
Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension TrialAlpesh Shah, Alvin Estilo, Pamela L Sheridan, et al.
Pageof 3